Status:
COMPLETED
Neuromuscular Monitoring:TOFCuff Versus EMG
Lead Sponsor:
Servei Central d'Anestesiologia
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18-65 years
Brief Summary
Mechanomyography (MMG) is considered the gold-standard for neuromuscular blockade (NMB) monitoring. However, it is quite bulky and difficult to use on a routine basis. Therefore, alternative methods l...
Detailed Description
Neuromuscular relaxation of the patient during surgery is necessary for multiple reasons, such as facilitating intubation or improving the effectiveness of some surgical procedures. Premature extubati...
Eligibility Criteria
Inclusion
- ASA I-II
- Patients who give their written informed consent
- Elective surgery under general anesthesia that according to the anesthetic plan muscle relaxants will be administered
Exclusion
- Patients who refuse to give their informed consent
- Patients who present any of the contraindications for the devices used in the study
- Patients who are participating or have participated in a clinical trial during the 4 weeks prior to inclusion
- Women of childbearing age who do not use effective contraceptive methods, pregnant women, with suspicion of pregnancy or breast-feeding
- Patients with the following criteria: upper limb peripheral vascular pathologies, a difficult airway, myasthenia gravis and other neuromuscular diseases, use of medication that may alter NMT
Key Trial Info
Start Date :
January 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 10 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04282213
Start Date
January 15 2020
End Date
May 10 2020
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Médico Teknon
Barcelona, Spain, 08022